2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

Data Compilation
#PharmaFlow

Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

Stock Recap
#PipelineProspector

PIPERACILLIN; TAZOBACTAM

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 14 USDMF, 13 CEP/COS, 13 JDMF, 3 EU WC, 13 KDMF, 14 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

164 FDF Dossiers, 67 FDA Orange Book, 53 Europe, 13 South Africa, 31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML, INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML, INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 Nanjing Well Pharmaceutical, 1 Actylis, 4 Roquette

EXCIPIENTS BY APPLICATIONS

4 Parenteral, 2 Fillers, Diluents & Binders, 1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 51 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

5 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 7 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/09/2024	Fresenius Kabi AB Brunna	Sweden	Sangjin Corporation	20220120-210-J-1216	Piperacillin sodium·tazobactam sodium	2022-01-20	Fresenius Kabi IPSUM SRL@[Piperacillin Hydrate Manufacturer]Fresenius Kabi IPSUM SRL@[Tazobactam Manufacturer]JiangXi Fushine Pharmaceutical Co., Ltd.	Sweden	Via San Leonardo, 23 – 45010 VILLADOSE (RO), Italy@[Piperacillin Hydrate Manufacture]Via San Leonardo, 23 – 45010 VILLADOSE (RO), Italy@[Tazobactam Manufacture]No.2 Yuli Industrial Zone, Changjiang District, Jingdezhen City, Jiangxi Province, China.
28/09/2024	Fresenius Kabi AB Brunna	Sweden	Aging Life Science Co., Ltd.	20200813-210-J-716	Piperacillin sodium·tazobactam sodium (8:1)	2020-08-13	Fresenius Kabi IPSUM SRL@[Tazobactam manufacturer]Jiangxi Fushine Pharmaceutical Co., Ltd.	Sweden	Via San Leonardo, 23 – 45010 VILLADOSE (RO), Italy@[Tazobactam Manufactory]No. 2, Yuli Industrial Zone, Changjiang District, Jingdezhen City, Jiangxi Province, China

List of Drug Master Files (KDMF) for Piperacillin + Tazobactam Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

PIPERACILLIN; TAZOBACTAM

PIPERACILLIN; TAZOBACTAM

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

14 USDMF

13 CEP/COS

13 JDMF

3 EU WC

13 KDMF

14 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

FINISHED DOSAGE FORMULATIONS

164 FDF Dossiers

67 FDA Orange Book

53 Europe

13 South Africa

31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML

INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML

INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 Nanjing Well Pharmaceutical

1 Actylis

4 Roquette

EXCIPIENTS BY APPLICATIONS

4 Parenteral

2 Fillers, Diluents & Binders

1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

51 Finished Drug Prices

5 Annual Reports

MARKET PLACE

5 APIs

5 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

2 USP

7 Others

Filters

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons